PISCATAWAY, NJ. — Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Pomalidomide Capsules [pom-a-LID-oh-mide], generic for Pomalyst®.
Pomalidomide capsules are available in 1 mg, 2 mg, 3 mg, and 4 mg strengths in bottles of 21 capsules.
As part of Camber’s initiative to supply accessible, affordable medicine, Pomalidomide Capsules are backed by a copay program.
Pomalidomide Capsules are a REMS product that requires distributors to be enrolled in the corresponding REMS program.
To learn more about the Pomalidomide Capsules REMS program, click here.
